The Supreme Court on Monday rejected an appeal by a drug maker over a judge's ruling that information Pfizer withheld during a Lipitor patent case was immaterial. Ranbaxy Laboratories had asked the justices to hear the case, which involves patents of Lipitor manufacturer Pfizer for the drug used to treat high cholesterol. Pfizer alleged infringement of two patents when Ranbaxy sought FDA approval to market a generic version of Lipitor, the world's most widely prescribed drug.
April 03, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The Supreme Court on Monday rejected an appeal by a drug maker over a judge’s ruling that information Pfizer withheld during a Lipitor patent case was immaterial.
Ranbaxy Laboratories Ltd. had asked the justices to hear the case, which involves patents of Lipitor manufacturer Pfizer Inc. for the drug used to treat high cholesterol.
Presented by BigVoodoo
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Women Leaders in Consulting Awards honors the industry standouts and rising stars who are making a mark within the profession.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
General Statement of DutiesPerforms legal work involving full litigation of all types of matters both for and against the Town, including al...
Shipman & Goodwin LLP is seeking a attorney to expand our national commercial real estate lending practice. Candidates should have a mi...
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
